trial · primary record
Mizagliflozin 5 mg
Postbariatric Hypoglycemia
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2028-01 |
| Primary endpoint | Number of combined Level 2 (as measured by self-monitored blood glucose) and Level 3 hypoglycemic events (as measured by diary entry and adjudicated) |
| Registry ID | NCT07760961 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:58.311Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07760961
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.